Form 4: Trevi Therapeutics' Chief Scientific Officer Executes Stock Options and Sells Shares
SEC Form 4
Thomas Sciascia, Chief Scientific Officer of Trevi Therapeutics, exercised stock options and sold shares of common stock between August 14 and August 16, 2024.
Summary
- Thomas Sciascia, the Chief Scientific Officer of Trevi Therapeutics, executed stock options to acquire common stock at a price of $1.43 per share.
- He then sold portions of these shares on the open market at prices ranging from $2.75 to $2.8020.
- The transactions occurred between August 14 and August 16, 2024.
- The total number of shares sold was 31,505.
- Following these transactions, Sciascia directly owns 220,315 shares of Trevi Therapeutics common stock.
- He also holds options to purchase 16,496 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares for personal financial management.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 11/25/2014 | Date stock option was granted. |
| 11/25/2015 | 25% of the shares underlying the option vested. |
| 11/25/2018 | Remaining 75% of the shares vested in equal monthly installments. |
| 08/14/2024 | First day of reported transactions: exercising options and selling shares. |
| 08/15/2024 | Second day of reported transactions: exercising options and selling shares. |
| 08/16/2024 | Third day of reported transactions: exercising options and selling shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.